SLACK, Inc.

SHERPA: Unknown

People

  1. Brennan
    Brennan
  2. Abramson
    Abramson
  3. Francis
    Francis
  4. Myskowski
    Myskowski
  5. Shike
    Shike
  6. Dupont
    Dupont
  7. O'Reilly
    O'Reilly
  8. Kris
    Kris
  9. Bajorin
    Bajorin
  10. Bosl
    Bosl

Groups

  1. Department of Medicine (35)
  2. Surgery (35)
  3. Division of Subspecialty Medicine (22)
  4. Sloan Kettering Institute Faculty (20)
  5. Pediatrics, Department of (17)
  6. Molecular Pharmacology and Chemistry Program Faculty (14)
  7. Sarcoma Surgeons (14)
  8. Nursing (12)
  9. Dermatology Service (9)
  10. Dermatology (9)
Search Within
Formats
  1. Meeting Abstract (137)
  2. Journal Article (37)
  3. Miscellaneous (5)
  4. Editorial (3)
  5. Book Section (2)
  6. Correspondence (1)
  7. Review (1)
Groups
  1. Department of Medicine (35)
  2. Surgery (35)
  3. Division of Subspecialty Medicine (22)
  4. Sloan Kettering Institute Faculty (20)
  5. Pediatrics, Department of (17)
  6. Molecular Pharmacology and Chemistry Program Faculty (14)

More Groups

People
  1. Maurie Markman (26)
  2. Thomas Hakes (14)
  3. John Pinto (13)
  4. Murray Brennan (12)
  5. Richard Rivlin (12)
  6. Bonnie Reichman (11)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (4)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Clinical Research (157)
  2. Journal of Pediatric Ophthalmology and Strabismus (11)
  3. Orthopedics (4)
  4. Pediatric Annals (4)
  5. Psychiatric Annals (3)
  6. Journal of Continuing Education in Nursing (2)

More Publications

Results (186)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Regulation of genes for perforin and serine esterases in the human T leukemia cell line (JURKAT)
    Meeting Abstract

    Cha, I.; Trapani, J. A.; Dupont, B.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • A model to examine cost versus benefit of anti-neoplastic therapy
    Meeting Abstract

    Markman, M.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Support for an advantage of intraperitoneal (IP) cisplatin (DDP) therapy (RX) over continued intravenous (IV) cisplatin in patients with residual ovarian-carcinoma (ROC)
    Meeting Abstract

    Markman, M.; Hakes, T.; Reichman, B.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Studies on RAS oncogene mutations in malignant melanomas and dysplastic nevi
    Meeting Abstract

    McNutt, N. S.; Mentle, I. R.; Albino, A. P.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Modulation of a glycolipid antigen, GD3, in human malignant melanoma
    Meeting Abstract

    Granberry, M. E.; Leong, S. P. L.; Houghton, A. N.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Discussions of cost in the peer-reviewed medical literature
    Meeting Abstract

    Markman, M.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Riboflavin deficiency intensifies depletion of lens glutathione by adriamycin
    Meeting Abstract

    Dutta, P.; Pinto, J.; Rivlin, R. S.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Adriamycin enhances aldosterone levels in normal chow-fed and riboflavin-deficient rats
    Meeting Abstract

    Pinto, J.; Delman, B.; Raiczyk, G.; Dutta, P.; Nisselbaum, J.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Leu 4+ epidermal staining with multiple basal cell carcinomas after bone marrow transplantation
    Meeting Abstract

    Lilienfeld, G. S.; Knowles, R.; Flomenberg, N.; Safai, B.; Myskowski, P. L.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Results of external beam radiation for children with retinoblastoma: A comparison of two techniques
    Journal Article

    McCormick, B.; Ellsworth, R.; Abramson, D.; LoSasso, T.; Grabowski, E.
    Journal of Pediatric Ophthalmology and Strabismus (1989)

    Fulltext@MSK | Save

    • SLACK, Inc. – authorized name for: